First Time Loading...
G

Glenmark Life Sciences Ltd
NSE:GLS

Watchlist Manager
Glenmark Life Sciences Ltd
NSE:GLS
Watchlist
Price: 830.05 INR 1.07% Market Closed
Updated: May 16, 2024

Glenmark Life Sciences Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Glenmark Life Sciences Ltd
Interest Income Expense Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
G
Glenmark Life Sciences Ltd
NSE:GLS
Interest Income Expense
-₹15.5m
CAGR 3-Years
74%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Interest Income Expense
-₹1.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Interest Income Expense
-₹898.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
5%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Interest Income Expense
-₹1.9B
CAGR 3-Years
11%
CAGR 5-Years
25%
CAGR 10-Years
-15%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Interest Income Expense
₹2.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Interest Income Expense
-₹3.8B
CAGR 3-Years
0%
CAGR 5-Years
5%
CAGR 10-Years
-23%

See Also

What is Glenmark Life Sciences Ltd's Interest Income Expense?
Interest Income Expense
-15.5m INR

Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Interest Income Expense amounts to -15.5m INR.

What is Glenmark Life Sciences Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
25%

The average annual Interest Income Expense growth rates for Glenmark Life Sciences Ltd have been 74% over the past three years , 25% over the past five years .